KOR

e-Article

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
Document Type
Article
Source
In: Trials. (Trials, December 2024, 25(1))
Subject
Language
English
ISSN
17456215